No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1c1bA, 1.0000, 0.00, 1.000, 536, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA- 186
2, 1rthA, 0.9928, 0.64, 1.000, 542, 422, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
3, 3dleA, 0.9927, 0.64, 1.000, 534, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GF128590.
4, 1jlaA, 0.9905, 0.51, 0.998, 546, 420, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
5, 1rtiA, 0.9904, 0.86, 1.000, 542, 422, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
6, 1rt2A, 0.9898, 0.76, 1.000, 542, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651
7, 1s1vA, 0.9895, 0.68, 0.995, 533, 421, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
8, 1rt1A, 0.9895, 0.77, 1.000, 538, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442
9, 1fkpA, 0.9882, 0.84, 0.998, 541, 422, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
10, 1c1cA, 0.9875, 0.84, 1.000, 536, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK- 6123
11, 1rt6A, 0.9844, 0.94, 1.000, 538, 422, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38
12, 1klmA, 0.9829, 0.91, 1.000, 537, 421, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152
13, 1jlfA, 0.9826, 0.99, 0.998, 538, 422, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
14, 1tkxA, 0.9824, 0.86, 1.000, 534, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745
15, 3dolA, 0.9810, 1.07, 0.995, 536, 422, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW695634.
16, 1c0uA, 0.9799, 1.07, 1.000, 538, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934
17, 1rt7A, 0.9796, 0.87, 1.000, 535, 419, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84
18, 1jlbA, 0.9794, 0.83, 0.990, 549, 418, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
19, 2opsA, 0.9792, 0.92, 0.998, 535, 419, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
20, 3dmjA, 0.9786, 0.91, 0.995, 531, 419, CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
21, 3dlgA, 0.9781, 0.98, 1.000, 531, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
22, 1jlqA, 0.9781, 1.14, 0.993, 533, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94
23, 3dokA, 0.9779, 1.15, 0.995, 535, 422, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248.
24, 1rt4A, 0.9774, 0.81, 0.998, 536, 417, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781
25, 1rtjA, 0.9768, 1.16, 1.000, 542, 422, MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS
26, 1s1tA, 0.9765, 0.82, 0.998, 533, 417, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
27, 1dttA, 0.9765, 1.07, 0.993, 540, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 2 (PETT130A94)
28, 1rt5A, 0.9764, 0.85, 0.998, 536, 417, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10
29, 3dm2A, 0.9757, 0.99, 0.998, 531, 419, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
30, 1jlgA, 0.9746, 0.93, 1.000, 529, 417, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
31, 2oprA, 0.9683, 1.10, 0.998, 538, 417, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
32, 1fkoA, 0.9625, 1.52, 0.993, 542, 422, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
33, 1jkhA, 0.9608, 1.40, 0.986, 550, 419, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
34, 1s1xA, 0.9593, 1.38, 0.986, 545, 418, CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
35, 1jlcA, 0.9580, 1.21, 0.998, 534, 414, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
36, 1jleA, 0.9421, 1.10, 1.000, 524, 406, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE
37, 3i0rA, 0.9377, 2.05, 0.981, 545, 422, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 3
38, 2rkiA, 0.9376, 2.09, 0.976, 557, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
39, 1lwfA, 0.9375, 1.71, 0.993, 542, 415, CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE
40, 3lanA, 0.9373, 2.09, 0.981, 553, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-BUTYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
41, 2b6aA, 0.9369, 2.21, 0.979, 558, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50
42, 1ikwA, 0.9368, 2.06, 0.974, 557, 422, WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ
43, 3i0sA, 0.9360, 2.10, 0.976, 558, 422, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7
44, 3lamA, 0.9359, 2.11, 0.981, 553, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-PROPYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
45, 3lalA, 0.9359, 2.12, 0.976, 553, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-ETHYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
46, 1ikyA, 0.9355, 2.11, 0.972, 557, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194
47, 4i7fA, 0.9345, 2.16, 0.976, 552, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A PHOSPHONATE ANALOG OF NEVIRAPINE
48, 3c6tA, 0.9343, 2.13, 0.976, 559, 422, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 14
49, 3lakA, 0.9342, 2.15, 0.976, 553, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-HETEROCYCLE PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
50, 3ffiA, 0.9342, 2.17, 0.969, 549, 422, HIV-1 RT WITH PYRIDONE NON-NUCLEOSIDE INHIBITOR
51, 2rf2A, 0.9340, 2.13, 0.974, 554, 422, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI)
52, 5fdlA, 0.9336, 2.16, 0.964, 550, 422, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH IDX899
53, 2wonA, 0.9336, 2.16, 0.976, 557, 422, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE).
54, 1ikxA, 0.9336, 2.13, 0.972, 557, 422, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721
55, 1ikvA, 0.9335, 2.08, 0.974, 556, 421, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ
56, 3drsA, 0.9333, 2.16, 0.974, 549, 422, HIV REVERSE TRANSCRIPTASE K103N MUTANT IN COMPLEX WITH INHIBITOR R8D
57, 1hniA, 0.9333, 2.25, 0.972, 558, 422, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION
58, 4kkoA, 0.9332, 2.35, 0.969, 554, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-METHOXY-6-(2-MORPHOLINOETHOXY)-135-TRIAZIN-2-YL)AMINO)-2-((3- METHYLBUT-2-EN-1-YL)OXY)BENZONITRILE (JLJ513) A NON-NUCLEOSIDE INHIBITOR
59, 3lp1A, 0.9331, 2.17, 0.972, 554, 422, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
60, 3di6A, 0.9331, 2.18, 0.974, 551, 422, HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR
61, 2yngA, 0.9329, 2.18, 0.976, 560, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK560
62, 3drrA, 0.9326, 2.17, 0.974, 558, 422, HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E
63, 4kv8A, 0.9325, 2.19, 0.976, 554, 422, CRYSTAL STRUCTURE OF HIV RT IN COMPLEX WITH BILR0355BS
64, 3qipA, 0.9324, 2.13, 0.974, 554, 422, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH AN RNASE H INHIBITOR AND NEVIRAPINE
65, 2ynhA, 0.9324, 2.19, 0.976, 560, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK500
66, 3dyaA, 0.9321, 2.20, 0.969, 551, 422, HIV-1 RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 1
67, 2yniA, 0.9320, 2.20, 0.976, 560, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK952
68, 3e01A, 0.9319, 2.20, 0.974, 552, 422, HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2
69, 3drpA, 0.9317, 2.19, 0.976, 558, 422, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E
70, 2womA, 0.9314, 2.20, 0.974, 557, 422, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N).
71, 3megA, 0.9313, 2.17, 0.979, 552, 422, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
72, 4ncgA, 0.9312, 2.21, 0.976, 553, 422, DISCOVERY OF DORAVIRINE AN ORALLY BIOAVAILABLE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR POTENT AGAINST A WIDE RANGE OF RESISTANT MUTANT HIV VIRUSES
73, 5vz6A, 0.9309, 2.21, 0.969, 554, 422, HIV REVERSE TRANSCRIPTASE COMPLEXED WITH (E)-3-(PYRIMIDIN-2-YL)-N-(5- (5;6;7;8-TETRAHYDRONAPHTHALEN-2-YL)-1H-PYRAZOL-3-YL)ACRYLAMIDE 
74, 3c6uA, 0.9309, 2.20, 0.976, 558, 422, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 22
75, 3lp0A, 0.9308, 2.21, 0.972, 555, 422, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
76, 3t1aA, 0.9305, 2.23, 0.972, 554, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M05
77, 4ko0A, 0.9304, 2.37, 0.969, 555, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH AN ANILINYLPYRIMIDINE DERIVATIVE (JLJ-135)
78, 4ig3A, 0.9302, 2.39, 0.969, 556, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT NEAR KNUCKLES SITE
79, 2ynfA, 0.9299, 2.22, 0.976, 557, 422, HIV-1 REVERSE TRANSCRIPTASE Y188L MUTANT IN COMPLEX WITH INHIBITOR GSK560
80, 4ig0A, 0.9298, 2.40, 0.993, 556, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 507 SITE
81, 4idkA, 0.9296, 2.41, 0.974, 556, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 428 SITE
82, 4h4oA, 0.9296, 2.33, 0.972, 549, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH (E)-3-(3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)- 4- FLUOROPHENOXY)-5-FLUOROPHENYL)ACRYLONITRILE (JLJ506) A NON- NUCLEOSIDE INHIBITOR
83, 3is9A, 0.9291, 2.43, 0.986, 554, 422, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 33 -(6-METHOXY-6-OXOHEX-1-ENE-11- DIYL)BIS(5-CYANO-6-METHOXYBENZOATE).
84, 4ifyA, 0.9289, 2.42, 0.969, 556, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE KNUCKLES SITE
85, 2ykmA, 0.9289, 2.23, 0.972, 557, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
86, 2jleA, 0.9289, 2.25, 0.974, 545, 422, NOVEL INDAZOLE NNRTIS CREATED USING MOLECULAR TEMPLATE HYBRIDIZATION BASED ON CRYSTALLOGRAPHIC OVERLAYS
87, 5vqwA, 0.9288, 2.31, 0.967, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON-NUCLEOSIDE INHIBITOR
88, 5vqtA, 0.9288, 2.31, 0.976, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 2- CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
89, 3meeA, 0.9288, 2.20, 0.981, 552, 422, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
90, 4ifvA, 0.9287, 2.42, 0.969, 556, 422, DETECTING ALLOSTERIC SITES OF HIV-1 REVERSE TRANSCRIPTASE BY X-RAY CRYSTALLOGRAPHIC FRAGMENT SCREENING
91, 3tamA, 0.9287, 2.26, 0.972, 553, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M06
92, 5vqyA, 0.9286, 2.30, 0.971, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
93, 5vqrA, 0.9285, 2.29, 0.995, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON- NUCLEOSIDE INHIBITOR
94, 5vqqA, 0.9285, 2.32, 0.976, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N-METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
95, 5c25A, 0.9285, 2.42, 0.969, 554, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 6- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-57-DIMETHYL-2- NAPHTHONITRILE (JLJ639) A NON-NUCLEOSIDE INHIBITOR
96, 2ze2A, 0.9285, 2.34, 0.969, 552, 421, CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
97, 3t19A, 0.9284, 2.27, 0.974, 554, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (WILD TYPE) IN COMPLEX WITH INHIBITOR M05
98, 1hnvA, 0.9284, 2.31, 0.974, 558, 422, STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
99, 6eliA, 0.9283, 2.33, 0.971, 556, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE AND AN RNASE H INHIBITOR XZ462 
100, 5vqzA, 0.9283, 2.30, 0.971, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
101, 5vqxA, 0.9283, 2.31, 0.974, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
102, 4id5A, 0.9283, 2.44, 0.969, 556, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE RNASE H PRIMER GRIP SITE
103, 5vquA, 0.9281, 2.30, 0.993, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N- METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
104, 5vqvA, 0.9279, 2.32, 0.974, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
105, 2b5jA, 0.9276, 2.40, 0.979, 552, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481
106, 4rw8A, 0.9275, 2.39, 0.972, 548, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR 
107, 5cyqA, 0.9273, 2.45, 0.972, 548, 422, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-BROMOPYRAZOLE
108, 3irxA, 0.9272, 2.45, 0.993, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(37-DIMETHYL-2-OXO-23-DIHYDROBENZO[D]OXAZOL-5-YL)-5- (5-METHYL-134-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3- METHYLBENZOTHIOATE.
109, 5tuqA, 0.9268, 2.52, 0.974, 555, 422, CRYSTAL STRUCTURE OF A 6-CYCLOHEXYLMETHYL-3-HYDROXYPYRIMIDINE-24- DIONE INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
110, 4kfbA, 0.9268, 2.45, 0.972, 556, 422, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT NNRTI ADJACENT SITE
111, 2yknA, 0.9267, 2.22, 0.957, 557, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
112, 1lweA, 0.9264, 1.90, 0.959, 542, 414, CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE
113, 5k14A, 0.9263, 2.12, 0.974, 536, 418, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 26-DIFLUOROPHENYL DAPY ANALOG
114, 5hbmA, 0.9262, 2.40, 0.972, 552, 422, CRYSTAL STRUCTURE OF A DIHYDROXYCOUMARIN RNASE H ACTIVE-SITE INHIBITOR IN COMPLEX WITH HIV-1 REVERSE TRANSCRIPTASE
115, 5c42A, 0.9262, 2.43, 0.969, 544, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K101P) VARIANT IN COMPLEX WITH 8-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
116, 2be2A, 0.9262, 2.49, 0.974, 552, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239
117, 3m8qA, 0.9261, 2.29, 0.979, 554, 422, HIV-1 RT WITH AMINOPYRIMIDINE NNRTI
118, 3qlhA, 0.9259, 2.44, 0.976, 555, 421, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH MANICOL AT THE RNASE H ACTIVE SITE AND TMC278 (RILPIVIRINE) AT THE NNRTI BINDING POCKET
119, 2vg7A, 0.9258, 2.16, 0.974, 544, 420, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
120, 3m8pA, 0.9257, 2.27, 0.979, 551, 422, HIV-1 RT WITH NNRTI TMC-125
121, 6dugA, 0.9254, 2.48, 0.972, 556, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE K101P MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
122, 3lp2A, 0.9254, 2.30, 0.972, 554, 422, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
123, 2vg6A, 0.9253, 2.17, 0.962, 548, 420, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
124, 1s1uA, 0.9251, 2.11, 0.978, 524, 418, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
125, 4o44A, 0.9250, 2.40, 0.972, 552, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-6-(3-MORPHOLINOPROPOXY)-135-TRIAZIN-2-YL)AMINO) BENZONITRILE (JLJ529) A NON-NUCLEOSIDE INHIBITOR
126, 1s1wA, 0.9250, 2.10, 0.981, 524, 418, CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
127, 6c0nA, 0.9247, 2.50, 0.969, 556, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR 25A 
128, 3nbpA, 0.9247, 2.32, 0.979, 554, 422, HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2
129, 1bqnA, 0.9246, 2.41, 0.972, 558, 422, TYR 188 LEU HIV-1 RT/HBY 097
130, 4g1qA, 0.9245, 2.41, 0.974, 556, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE (TMC278 EDURANT) A NON-NUCLEOSIDE RT-INHIBITING DRUG
131, 6c0pA, 0.9244, 2.50, 0.974, 556, 422, CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
132, 2i5jA, 0.9244, 2.42, 0.974, 552, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH AN RNASE H INHIBITOR
133, 4iclA, 0.9243, 2.41, 0.974, 556, 421, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE INCOMING DNTP BINDING SITE
134, 4i2qA, 0.9243, 2.51, 0.964, 556, 422, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) ANALOGUE
135, 2vg5A, 0.9243, 2.19, 0.969, 551, 420, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
136, 4lslA, 0.9242, 2.45, 0.972, 548, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ476) A NON-NUCLEOSIDE INHIBITOR
137, 4i2pA, 0.9242, 2.41, 0.974, 554, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) BASED ANALOGUE
138, 3medA, 0.9241, 2.28, 0.979, 552, 422, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
139, 6dufA, 0.9240, 2.51, 0.964, 556, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE V106A/F227L MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
140, 2zd1A, 0.9238, 2.40, 0.974, 554, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
141, 3bgrA, 0.9236, 2.45, 0.964, 554, 421, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
142, 2banA, 0.9236, 2.42, 0.974, 552, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208
143, 5tepA, 0.9234, 2.28, 0.969, 545, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ649) A NON-NUCLEOSIDE INHIBITOR
144, 5cymA, 0.9233, 2.44, 0.969, 546, 420, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-IODOPYRAZOLE
145, 1uwbA, 0.9231, 2.41, 0.972, 558, 422, TYR 181 CYS HIV-1 RT/8-CL TIBO
146, 1s9gA, 0.9231, 2.51, 0.972, 543, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.
147, 1rt3A, 0.9230, 2.02, 0.976, 520, 416, AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91
148, 1revA, 0.9230, 2.14, 0.978, 524, 418, HIV-1 REVERSE TRANSCRIPTASE
149, 6c0rA, 0.9229, 2.53, 0.964, 556, 422, CRYSTAL STRUCTURE OF HIV-1 K103N/Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
150, 4o4gA, 0.9229, 2.56, 0.969, 554, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-135-TRIAZIN-2-YL)AMINO)BENZONITRILE (JLJ527) A NON-NUCLEOSIDE INHIBITOR
151, 1bqmA, 0.9227, 2.45, 0.974, 556, 422, HIV-1 RT/HBY 097
152, 6c0lA, 0.9226, 2.57, 0.969, 556, 422, CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
153, 1hpzA, 0.9225, 2.48, 0.972, 556, 422, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
154, 6cgfA, 0.9224, 2.57, 0.967, 556, 422, CRYSTAL STRUCTURE OF HIV-1 Y188L MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
155, 5terA, 0.9221, 2.44, 0.993, 547, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5- CHLORO-7-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-8-METHYL-2-NAPHTHONITRILE (JLJ651) A NON-NUCLEOSIDE INHIBITOR
156, 1s6qA, 0.9220, 2.43, 0.969, 552, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681
157, 4lsnA, 0.9219, 2.55, 0.972, 549, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-BROMO-5-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ518) A NON-NUCLEOSIDE INHIBITOR
158, 6duhA, 0.9218, 2.54, 0.967, 556, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE Y181I MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
159, 6c0jA, 0.9217, 2.58, 0.969, 556, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR K-5A2 
160, 4h4mA, 0.9216, 2.49, 0.976, 548, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
161, 3mecA, 0.9216, 2.25, 0.981, 550, 420, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
162, 5c24A, 0.9215, 2.36, 0.978, 537, 417, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-68- DIMETHYLINDOLIZINE-2-CARBONITRILE (JLJ605) A NON-NUCLEOSIDE INHIBITOR
163, 1tv6A, 0.9215, 2.31, 0.974, 535, 418, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94707
164, 5tw3A, 0.9214, 2.32, 0.969, 548, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)-4-FLUOROPHENOXY)- 7-FLUORO-2-NAPHTHONITRILE (JLJ636) A NON-NUCLEOSIDE INHIBITOR
165, 1hquA, 0.9213, 2.50, 0.967, 556, 422, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
166, 6c0oA, 0.9212, 2.46, 0.971, 556, 421, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
167, 6c0kA, 0.9211, 2.46, 0.974, 556, 421, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
168, 4mfbA, 0.9211, 2.38, 0.971, 544, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 8-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY) INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
169, 1dtqA, 0.9204, 2.19, 0.983, 524, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 1 (PETT131A94)
170, 1vruA, 0.9202, 2.25, 0.981, 525, 419, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
171, 1fk9A, 0.9199, 2.17, 0.981, 519, 417, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP- 266(EFAVIRENZ)
172, 1tvrA, 0.9195, 2.48, 0.979, 558, 422, HIV-1 RT/9-CL TIBO
173, 1tkzA, 0.9185, 2.14, 0.983, 516, 416, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576
174, 1tl1A, 0.9181, 2.14, 0.983, 516, 416, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211
175, 1s6pA, 0.9179, 2.48, 0.972, 552, 422, CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943
176, 5vqsA, 0.9178, 2.59, 0.971, 551, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON- NUCLEOSIDE INHIBITOR
177, 1tl3A, 0.9177, 2.15, 0.983, 516, 416, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557
178, 1vrtA, 0.9173, 2.26, 0.983, 524, 418, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
179, 1s9eA, 0.9170, 2.50, 0.974, 552, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385
180, 2hndA, 0.9159, 2.26, 0.978, 522, 418, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
181, 1sv5A, 0.9154, 2.69, 0.979, 552, 421, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335
182, 1tktA, 0.9153, 2.15, 0.981, 515, 415, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318
183, 1suqA, 0.9150, 2.53, 0.976, 552, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545
184, 2opqA, 0.9146, 2.16, 0.981, 515, 415, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
185, 6bsgA, 0.9140, 2.29, 0.971, 545, 414, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN AN RNA HYDROLYSIS-OFF MODE
186, 2oppA, 0.9125, 2.23, 0.983, 518, 415, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
187, 6bshA, 0.9124, 2.28, 0.971, 544, 413, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN THE RNA HYDROLYSIS MODE
188, 6bsiA, 0.9122, 2.22, 0.971, 543, 412, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID CONTAINING THE POLYPURINE-TRACT SEQUENCE
189, 2hnyA, 0.9113, 2.34, 0.978, 522, 418, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
190, 2hnzA, 0.9097, 2.19, 0.971, 516, 414, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
191, 4b3oA, 0.9094, 2.17, 0.995, 540, 410, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
192, 6bsjA, 0.9091, 2.32, 0.971, 543, 412, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID SEQUENCE NON- PREFERRED FOR RNA HYDROLYSIS
193, 1eetA, 0.9091, 2.14, 0.976, 542, 411, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204
194, 3qo9A, 0.9090, 2.69, 0.986, 553, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
195, 4rw4A, 0.9087, 2.41, 0.990, 538, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103NY181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
196, 4rw9A, 0.9086, 2.39, 0.993, 538, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON- NUCLEOSIDE INHIBITOR
197, 4b3qA, 0.9084, 2.29, 0.983, 543, 412, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
198, 4rw7A, 0.9080, 2.39, 0.990, 538, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR
199, 1lw2A, 0.9080, 2.35, 0.981, 518, 416, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91
200, 3hvtA, 0.9075, 2.58, 0.902, 555, 419, STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
201, 4rw6A, 0.9072, 2.42, 0.993, 538, 412, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
202, 2ic3A, 0.9070, 2.76, 0.972, 558, 422, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097
203, 4puoC, 0.9065, 2.87, 0.969, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
204, 4we1A, 0.9047, 2.73, 0.966, 542, 417, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ600)
205, 4q0bC, 0.9038, 2.88, 0.969, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
206, 4pwdC, 0.9035, 2.89, 0.969, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
207, 1lw0A, 0.9033, 2.26, 0.981, 512, 412, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
208, 3v81C, 0.9030, 2.89, 0.969, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
209, 4puoA, 0.9026, 2.83, 0.964, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
210, 3v81A, 0.9005, 2.89, 0.964, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
211, 4q0bA, 0.8998, 2.88, 0.964, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
212, 1ep4A, 0.8998, 2.19, 0.993, 522, 410, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S- 1153
213, 1lwcA, 0.8994, 2.20, 0.976, 506, 410, CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
214, 4pwdA, 0.8981, 2.91, 0.967, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
215, 1t03A, 0.8941, 2.80, 0.962, 558, 420, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
216, 1n5yA, 0.8911, 2.86, 0.962, 558, 420, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
217, 2hmiA, 0.8909, 2.86, 0.948, 558, 420, HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
218, 3klhA, 0.8907, 2.98, 0.962, 558, 422, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
219, 1j5oA, 0.8900, 2.82, 0.940, 558, 419, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
220, 1r0aA, 0.8839, 2.95, 0.960, 558, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
221, 1hysA, 0.8832, 3.01, 0.952, 553, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
222, 1n6qA, 0.8821, 2.97, 0.960, 558, 420, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
223, 5xn0C, 0.8763, 2.99, 0.945, 551, 419, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA BINARY COMPLEX
224, 5d3gA, 0.8689, 3.15, 0.960, 553, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
225, 4b3pA, 0.8675, 2.16, 0.995, 519, 391, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
226, 5xn0A, 0.8663, 3.12, 0.945, 551, 419, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA BINARY COMPLEX
227, 5d3gC, 0.8662, 3.21, 0.962, 553, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
228, 5hlfA, 0.8637, 3.26, 0.960, 554, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
229, 5hlfC, 0.8634, 3.24, 0.962, 553, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
230, 3v6dA, 0.8623, 3.42, 0.972, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
231, 5xn2A, 0.8610, 3.24, 0.940, 551, 419, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
232, 5i3uC, 0.8595, 3.34, 0.960, 553, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
233, 5i42A, 0.8582, 3.43, 0.960, 554, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
234, 3v6dC, 0.8569, 3.48, 0.955, 554, 421, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
235, 3kjvA, 0.8568, 3.14, 0.910, 549, 411, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
236, 5xn1A, 0.8561, 3.31, 0.945, 551, 419, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:ENTECAVIR-TRIPHOSPHATE TERNARY COMPLEX
237, 5xn2C, 0.8553, 3.32, 0.918, 551, 417, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
238, 5txnA, 0.8538, 3.52, 0.960, 555, 421, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
239, 4r5pA, 0.8538, 3.57, 0.969, 555, 422, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
240, 5hp1A, 0.8537, 3.44, 0.962, 553, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
241, 5txmA, 0.8536, 3.53, 0.962, 556, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
242, 5txlA, 0.8535, 3.53, 0.962, 556, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
243, 5txoA, 0.8533, 3.52, 0.950, 556, 421, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
244, 3kleI, 0.8533, 3.50, 0.952, 560, 421, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
245, 5hroA, 0.8527, 3.38, 0.962, 551, 418, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
246, 5xn1C, 0.8526, 3.39, 0.931, 551, 418, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:ENTECAVIR-TRIPHOSPHATE TERNARY COMPLEX
247, 5txpA, 0.8523, 3.51, 0.938, 556, 420, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
248, 5i3uA, 0.8522, 3.36, 0.962, 550, 418, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
249, 1c0tA, 0.8514, 1.74, 0.976, 490, 378, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326
250, 5i42C, 0.8506, 3.54, 0.960, 554, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
251, 5hp1C, 0.8494, 3.50, 0.960, 553, 421, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
252, 1t05A, 0.8479, 3.55, 0.928, 554, 418, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE
253, 3v4iA, 0.8474, 3.55, 0.926, 555, 418, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
254, 3kleM, 0.8472, 3.53, 0.928, 560, 418, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
255, 3kk3A, 0.8471, 3.52, 0.890, 555, 418, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
256, 1rtdA, 0.8461, 3.63, 0.948, 554, 421, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
257, 3klfM, 0.8452, 3.60, 0.928, 553, 419, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
258, 3jsmA, 0.8452, 3.59, 0.928, 554, 418, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH TENOFOVIR-DIPHOSPHATE AS THE INCOMING NUCLEOTIDE SUBSTRATE
259, 3v4iC, 0.8438, 3.69, 0.936, 555, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
260, 3klfI, 0.8438, 3.64, 0.938, 553, 419, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
261, 5j2pA, 0.8435, 3.65, 0.931, 558, 419, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED EFDA-MP AT THE P-(POST-TRANSLOCATION) SITE AND A SECOND EFDA-MP AT THE N-(PRE-TRANSLOCATION) SITE
262, 4r5pC, 0.8435, 3.62, 0.931, 554, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
263, 5j2nA, 0.8424, 3.68, 0.931, 558, 419, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED EFDA-MP AT THE P-(POST-TRANSLOCATION) SITE AND DTMP AT THE N-(PRE- TRANSLOCATION) SITE
264, 5txmC, 0.8422, 3.66, 0.931, 556, 419, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
265, 3kleE, 0.8418, 3.61, 0.916, 560, 417, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
266, 5txlC, 0.8417, 3.67, 0.931, 556, 419, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
267, 3kleA, 0.8414, 3.62, 0.916, 560, 417, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
268, 5hroC, 0.8411, 3.56, 0.959, 551, 418, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
269, 3klgE, 0.8410, 3.64, 0.919, 554, 418, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
270, 5txpC, 0.8407, 3.67, 0.916, 556, 419, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
271, 5txnC, 0.8401, 3.68, 0.926, 555, 419, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
272, 3jytA, 0.8395, 3.67, 0.919, 554, 418, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS- DNA AND COMPLEXED WITH DATP AS THE INCOMING NUCLEOTIDE SUBSTRATE
273, 5txoC, 0.8392, 3.70, 0.916, 556, 419, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
274, 4pquA, 0.8385, 3.76, 0.936, 545, 420, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
275, 3klfA, 0.8371, 3.75, 0.936, 553, 419, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
276, 3klfE, 0.8366, 3.76, 0.936, 553, 419, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
277, 1rtdC, 0.8353, 3.78, 0.936, 554, 420, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
278, 3klgA, 0.8342, 3.74, 0.931, 554, 418, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
279, 5j2mA, 0.8336, 3.85, 0.926, 558, 419, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA AND EFDA-TRIPHOSPHATE A TRANSLOCATION-DEFECTIVE RT INHIBITOR
280, 4dg1A, 0.8332, 3.33, 0.936, 549, 389, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH POLYMORPHISM MUTATION K172A AND K173A
281, 3kk1A, 0.8332, 3.78, 0.945, 555, 418, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS- 9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
282, 4pquC, 0.8319, 3.83, 0.928, 545, 419, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
283, 5j2qA, 0.8301, 3.52, 0.931, 547, 408, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED A MISMATCHED EFDA-MP AT THE N-(PRE-TRANSLOCATION) SITE
284, 3kk2A, 0.8289, 3.88, 0.923, 555, 418, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
285, 3dlkA, 0.8252, 3.15, 0.943, 552, 383, CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE RT69A
286, 3ig1A, 0.8188, 3.43, 0.935, 552, 386, HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
287, 1hvuJ, 0.8097, 3.14, 0.960, 554, 375, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
288, 1hvuG, 0.8097, 3.14, 0.960, 554, 375, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
289, 1hvuD, 0.8097, 3.14, 0.960, 554, 375, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
290, 1hvuA, 0.8097, 3.14, 0.960, 554, 375, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
291, 6b19A, 0.8055, 3.02, 0.932, 508, 385, ARCHITECTURE OF HIV-1 REVERSE TRANSCRIPTASE INITIATION COMPLEX CORE 
292, 6aocA, 0.7979, 3.17, 0.955, 555, 376, CRYSTAL STRUCTURE OF AN N-HYDROXYTHIENOPYRIMIDINE-2;4-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE 
293, 3ithC, 0.7959, 3.24, 0.949, 556, 376, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
294, 3kliA, 0.7958, 3.16, 0.949, 551, 372, CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE
295, 4zhrA, 0.7954, 3.03, 0.922, 553, 373, STRUCTURE OF HIV-1 RT Q151M MUTANT
296, 6aocC, 0.7952, 2.97, 0.951, 557, 369, CRYSTAL STRUCTURE OF AN N-HYDROXYTHIENOPYRIMIDINE-2;4-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE 
297, 3ithA, 0.7900, 3.16, 0.954, 556, 373, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
298, 2iajA, 0.7891, 3.12, 0.954, 551, 370, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP
299, 5j1eC, 0.7849, 3.19, 0.957, 548, 368, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
300, 1qe1A, 0.7843, 3.24, 0.941, 556, 370, CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
301, 3isnC, 0.7837, 3.43, 0.955, 556, 376, CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
302, 5uv5C, 0.7812, 2.72, 0.964, 546, 359, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
303, 4mh8A, 0.7798, 4.01, 0.185, 453, 394, THE CRYSTAL STRUCTURE OF THE MONOMERIC REVERSE TRANSCRIPTASE FROM MOLONEY MURINE LEUKEMIA VIRUS
304, 1dloA, 0.7779, 3.29, 0.946, 556, 369, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
305, 1hqeA, 0.7770, 3.30, 0.940, 554, 369, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
306, 4hkqA, 0.7750, 3.75, 0.198, 441, 393, XMRV REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA HYBRID
307, 5j1eA, 0.7745, 2.96, 0.961, 541, 361, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
308, 1mu2A, 0.7707, 2.81, 0.582, 538, 352, CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE
309, 5dmqA, 0.7694, 4.20, 0.189, 609, 391, CRYSTAL STRUCTURE OF MOUSE ERF1 IN COMPLEX WITH REVERSE TRANSCRIPTASE (RT) OF MOLONEY MURINE LEUKEMIA VIRUS
310, 5uv5A, 0.7690, 3.08, 0.947, 534, 357, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
311, 1hmvG, 0.7670, 3.09, 0.950, 536, 359, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
312, 1hmvE, 0.7670, 3.09, 0.950, 536, 359, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
313, 1hmvC, 0.7670, 3.09, 0.950, 536, 359, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
314, 1hmvA, 0.7670, 3.09, 0.950, 536, 359, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
315, 4ol8A, 0.6763, 3.92, 0.169, 385, 349, TY3 REVERSE TRANSCRIPTASE BOUND TO DNA/RNA
316, 5ovnA, 0.6760, 4.61, 0.393, 530, 359, CRYSTAL STRUCURE OF FIV REVERSE TRANSCRIPTASE
317, 4ol8E, 0.6597, 4.05, 0.183, 376, 345, TY3 REVERSE TRANSCRIPTASE BOUND TO DNA/RNA
318, 4ol8B, 0.5303, 4.47, 0.189, 447, 275, TY3 REVERSE TRANSCRIPTASE BOUND TO DNA/RNA
319, 4ol8F, 0.5221, 4.30, 0.190, 422, 268, TY3 REVERSE TRANSCRIPTASE BOUND TO DNA/RNA
320, 2r2sA, 0.5008, 2.29, 0.256, 255, 227, CO(III)BLEOMYCINB2 BOUND TO D(ATTAGTTATAACTAAT) COMPLEXED WITH MMLV RT CATALYTIC FRAGMENT
